Corcept Therapeutics to Present Data at the 2019 American Association of Clinical Endocrinologists’ 28th Annual Congress
April 18, 2019 16:05 ET
|
Corcept Therapeutics Incorporated
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe...
Exponent Reports First Quarter of Fiscal Year 2019 Financial Results
April 18, 2019 16:05 ET
|
Exponent, Inc.
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today reported financial results for the first quarter of fiscal year 2019 ended March 29, 2019. ...
Colony Bankcorp Reports First Quarter Results
April 18, 2019 16:05 ET
|
Colony Bankcorp, Inc.
FITZGERALD, Ga., April 18, 2019 (GLOBE NEWSWIRE) -- Colony Bankcorp, Inc. (Nasdaq: CBAN) ("Colony" or the "Company") today reported net income of $2.84 million or $0.34 per diluted share for the...
Exponent Declares Regular Quarterly Dividend
April 18, 2019 16:05 ET
|
Exponent, Inc.
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.16 per share of common...
Highwoods Declares Quarterly Dividends
April 18, 2019 16:05 ET
|
Highwoods Properties, Inc.
RALEIGH, N.C., April 18, 2019 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) announces its Board of Directors today declared a cash dividend of $0.475 per share of common stock for the...
Avista builds on commitment to renewable energy with goal of 100 percent clean electricity by 2045
April 18, 2019 16:05 ET
|
Avista Corporation
SPOKANE, Wash., April 18, 2019 (GLOBE NEWSWIRE) -- Avista (NYSE: AVA), a leader in clean electricity, today announced its goal to serve its customers with 100 percent clean electricity by 2045 and...
SeaSpine to Report First Quarter 2019 Financial Results on May 1, 2019
April 18, 2019 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
Dynavax to Present Data on Toll-like Receptor 9 Agonist SD-101 at the ASCO Annual Meeting 2019
April 18, 2019 16:05 ET
|
Dynavax Technologies Corporation
BERKELEY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a fully-integrated biopharmaceutical company focused on discovering and developing novel...
Aduro Biotech Appoints Experienced Financial Executive, Frank Karbe, to its Board of Directors
April 18, 2019 16:05 ET
|
Aduro Biotech, Inc.
BERKELEY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical stage biopharmaceutical company developing therapies in the Stimulator of Interferon Genes (STING)...
Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
April 18, 2019 16:05 ET
|
Prothena Corporation plc
Results from final analysis of the composite primary endpoint were consistent with the futility analysis reported in April 2018Results from post hoc analyses revealed a potential survival benefit with...